eye tube Registration and Sign Up Information | eyetube

NEW EPISODE | May 27, 2020

Video

WATCH THIS WEEK'S EPISODE

IN THIS EPISODE

BMC Virtual Spring Symposium to Take Place This Weekend

Mass. Eye and Ear Develops Novel Gene-Based COVID-19 Vaccine Candidate

Port Delivery System With Ranibizumab Shows Positive Phase 3 Results in Wet AMD

VIEW ALL SEGMENTS

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

FREE WEBINAR
May 22, 2020 at 12PM PT (3PM ET)

Join us for timely insights from 4 leaders in scleral lenses. Learn more about these timely topics relating to the future of your practice in this 45 minute virtual meeting:

Reopening your practice
Patient safety - what is the new normal?
The future of scleral lens fitting
How new technologies have influenced scleral lens fitting

Includes live Q&A from around the world. Don't miss this live on demand learning opportunity

This live, interactive panel discussion features:

Thomas P. Arnold, OD, FSLS
Melissa Barnett, OD, FAAO, FSLS, FBCLA
Daddi Fadel, Dip Optom, FSLS
Christine Sindt, OD, FAAO, FSLS

CLICK HERE TO REGISTER FOR FREE

Join us for ICSC 2021 in Fort Lauderdale

July 23 - 24, 2021 | W Hotel Fort Lauderdale

Expect to learn about scleral lens topics such as upcoming scleral technologies, side effects of sclerals, solutions for fogging, toric peripheral curves, marketing your practice, ocular surface disease, and much more.

Learn More

View email in your browser

This sponsored message helps support the free educational content produced by Bryn Mawr Communications LLC.

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to BMC Group from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

YOUR RUNDOWN

What is the 5-year success rate of a corneal transplant?
The short answer? 76%.

A new study published in the Canadian Journal of Ophthalmology examined 596 patients who had primary penetrating keratoplasty between 2011 and 2017. The authors found the 3-year survival rate was 78%. At 5 years, the survival rate was 76%, and at 7 years it was 73%.

Is this different from what was previously published?
Yes. Previous studies that the success rates were higher, around 90% at 5 years.

In other news:
Floating the idea of same-day bilateral cataract surgeries?
In an editorial published in Ophthalmology, the authors suggest that the time for bilateral same-day cataract surgery is now.

WHAT YOUR PATIENT MIGHT ASK YOU

Can glasses protect me from COVID?
A recent study published in JAMA Ophthalmology found that glasses wearers may be less likely to be infected with COVID-19.

Tell me about the study.
The study examined 276 patients in Suizhou, China, who were hospitalized due to COVID-19. Of these patients, 30 wore glasses (16 were myopic and 14 were presbyopic). The 16 myopic patients with COVID-19 who wore their glasses for more than 8 hours per day accounted for 5.8% of patients in the study.

Why is this significant?
One of the main findings of this study was that patients with COVID-19 who wear glasses for more than 8 hours per day were relatively uncommon, representing only 5.8% of patients. The authors associated this with less susceptibility to COVID-19 infection.

Why do they think wearing glasses helps?
There are a couple of theories:
1. Wearing glasses prevents or discourages wearers from touching their eyes, thus avoiding transferring the virus from the hands to the eyes.
2. An abundance of the SARS-CoV-2 receptor angiotensin-converting enzyme 2 has been found on the ocular surface through which SARS-CoV-2 can enter the body. Wearing glasses may become a protective factor, reducing the risk of virus transfer to the eyes.

Why might my patient ask me about this?
Because this study made its way into mainstream media (here, here, here, and here, to name a few sources).

Should we recommend that everyone wear glasses?
Not yet. In fact, an infectious disease specialist at Johns Hopkins School of Medicine wrote a commentary on this study discussing some of its flaws.

SOCIAL MEDIA ROUNDUP

40.9
The percentage of US adults who have skipped medical care since COVID. (via)

The death of one brand of smart glasses inevitably means the birth of another.
Facebook and EssilorLuxottica announced their collaboration on a new generation of smart glasses. The first product will be branded Ray-Ban and is scheduled to launch in 2021. This news comes after VSP discontinued the production of their Level smart glasses. (via)

Looking for a new podcast?
Check out GlobalEyes! Drs. Tom Arnold and Melissa Barnett will be chatting with eye care practitioners from around the world and exploring the state of eye care in their home countries.

Thinking outside the box.
Lumenis is launching a traveling outdoor trade show. (via)

See you next week!

Jackie Garlich OD, FAAO
Editor & Founder // 20/20 Glance

Enjoy this email? Tell your friends to sign up here!

Have news or a comment to share?

send me an email!

Email Me

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to 20/20 Glance Newsletter from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

NEW ISSUE | MAY 2020

The latest issue of CRST celebrates progress toward gender equity in ophthalmology and considers the challenges that remain.

READ MAY ISSUE

THE TOP THREE ARTICLES YOU SHOULD BE READING:

1	The Gender Gap By Lisa Brothers Arbisser, MD; Ashley Brissette, MD, MSc, FRCSC; Sumitra S. Khandelwal, MD; Cynthia Matossian, MD, FACS; Cathleen M. McCabe, MD; Marguerite B. McDonald, MD, FACS; M. Amir Moarefi, MD; Lisa M. Nijm, MD, JD; Karolinne Maia Rocha, MD, PhD; Arsham Sheybani, MD; Denise M. Visco, MD, MBA; O. Bennett Walton IV, MD, MBA; George O. Waring IV, MD, FACS; and Blake K. Williamson, MD, MPH, MS Get candid insight into how the gender gap has shrunk in ophthalmology and hear from both genders how to influence further advances.
2	COVID-19: An Ageless, Borderless Battle By Sila Bal, MD, MPH Find out what the pandemic has taught one ophthalmology resident about grit.
3	Cases That Have Stuck With Me By Uday Devgan, MD; Mark Kontos, MD; Mark Lobanoff, MD; Michael E. Snyder, MD; and Elizabeth Yeu, MD Five ophthalmologists share memorable cases. What did they learn from those experiences?

Also in This Issue

Graftless Corneal Endothelial Replacement ?

How to Optimize Your Practice for Private Equity Purchase ?

Small Pupil, Dense Lens, Severe Zonulopathy ?

READ MAY ISSUE ?

FEATURED VIDEO IN
CORNEA

DSAEK for Decompensated Penetrating Graft and ICE Syndrome
By Ozana Moraru, MD


	WATCH NOW ON EYETUBE.NET

CATARACT & REFRACTIVE NEWS

05.11.20
Analysis: Ophthalmology Lost More Patient Volume Due to COVID-19 Than Any Other Specialty    READ MORE

05.11.20
Scientists Find Eye Cells Are a Prime Target for COVID-19 to Attach to    READ MORE

05.11.20
Oyster Point Announces Results of Phase 3 Trial of OC-01 Nasal Spray for Treatment of Signs and Symptoms of Dry Eye Disease    READ MORE

RECENT CATARACT & REFRACTIVE SURGERY Today ISSUES

stay updated on all things Cataract

click here

Advertise | Submit Breaking News | Contact Us

* Free print subscriptions are available to practicing physicians in the US.
All others, applicable subscription charges apply.

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.

You received this email because you are subscribed to Cataract & Refractive Surgery Today Newsletter from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us | Legal Disclaimer

Editorially independent content supported with advertising.

Outcomes With EDOF IOLs After Laser Refractive Surgery

Richard S. Davidson, MD, joins Neda Shamie, MD, to discuss a retrospective review that compared the visual outcomes of extended depth of focus (EDOF) IOLs in eyes with and without a history of laser refractive surgery. Are these IOLs an appropriate choice after LASIK and PRK?

CLICK HERE TO WATCH THE VIDEO

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

FEATURED NEWS STORY
Survey: Use of Virtual Education Soars; Telemedicine Remains a Small Percentage of Volume
Since the onset of the COVID-19 pandemic, the majority of ophthalmologists and optometrists are 'very likely' to participate in virtual education programs, while the percentage of those using telemedicine remains low compared to traditional care. That according to a recent survey conducted by Bryn Mawr Communications (BMC). The survey, which had 229 respondents, was conducted via email and social media in June.
VIEW STORY ?

OTHER COVID-19 NEWS
06.23.20
Gilead Looking to Test Easier-To-Use, Inhaled Version of Remdesivir
Gilead Sciences said Monday that it hopes to begin clinical trials this summer evaluating an inhaled formulation of remdesivir, administered via a nebuliser, to patients with COVID-19. The experimental antiviral, which the FDA authorized for emergency use in early May, is currently given intravenously through daily infusions to COVID-19 patients in hospital.
VIEW STORY ?

06.23.20
How Regeneron's COVID-19 Antibody Cocktail Cuts the Risk of Resistance
When Regeneron said in March that it would speed an antibody treatment into clinical trials for COVID-19, its scientists insisted a cocktail of two antibodies would be more effective than one alone. Now they're explaining why they chose the two antibodies that moved into human trials last week.
VIEW STORY ?

VIEW ALL COVID-19 COVERAGE

This resource has been made possible with support from our industry sponsors

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

TOP STORY OF THE WEEK
The Lancet Withdraws Major Hydroxychloroquine Study ?

TRENDING NEWS
06.04.20
SightGlass Vision Granted CE Mark for Eyeglasses That Slow Myopia Progression in Children ?

06.04.20
BVI Launches CryoTreq for Treatment of Retinal Tears and Detachments ?

06.04.20
Bausch + Lomb Receives FDA Clearance for Infuse Daily Disposable Silicone Hydrogel Contact Lenses ?

06.04.20
Aldeyra Therapeutics Reaches Agreement With FDA for Use of RASP as Dry Eye Disease Sign ?

06.02.20
Nicox Initiates First Phase 3 Trial of NCX 470 in Glaucoma ?

06.01.20
Ocugen to Discontinue Phase 3 oGVHD Trial ?

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.


What''s New to Eyetube.net: MAY 2020

A Jellyfish in the Eye

by Emanuele Siotto Pintor, MD, and Enrico Peiretti, MD

Emanuele Siotto Pintor, MD, and Enrico Peiretti, MD, share a case of a posttraumatic recurrent retinal detachment that resembles a jellyfish.
Watch Now >

Diagonal Haptics Capture of Anterior Rhexis in Compromised Posterior Capsule

by Lukan Mishev, MD

Lukan Mishev, MD, describes a technique of diagonal fixation of plate haptic IOLs with or without four independent haptics.
Watch Now >

Combining Mechanisms: Viscodilation, Trabeculectomy, and Hydrus Implantation

by Inder Paul Singh, MD

Inder Paul Singh, MD, describes combining various glaucoma procedures with complementary mechanisms of action to treat a patient with an IOP in the upper 30s and progressing moderate open-angle glaucoma.
Watch Now >

DSAEK for Decompensated Penetrating Graft and ICE Syndrome

by Ozana Moraru, MD

Ozana Moraru, MD, demonstrates a Descemet stripping automated endothelial keratoplasty (DSAEK) pull technique on a pseudophakic eye with endothelial decompensation and iridocorneal endothelial (ICE) syndrome.
Watch Now >

[3D Video] Persistent Fetal Vasculature Syndrome

by Alexandre Grandinetti, MD, PhD

Alexandre Grandinetti, MD, PhD, describes a case of a 4-month-old girl with anterior and posterior manifestations of persistent fetal vasculature syndrome.
Watch Now >

Stepwise Guide to Capsulorhexis in Intumescent Cataract

by Sourabh D. Patwardhan, MD

Sourabh D. Patwardhan, MD, demonstrates a five-step approach to performing the capsulorhexis in an eye with an intumescent cataract.
Watch Now >

Other Series:

Informed Consent
Telemedicine for Dry Eye Care

Presbyopia Unlocked
Getting Comfortable With Advanced Presbyopia-Correcting Technologies

New Retina Radio
COVID-19: Can Clinical Trials Proceed?

Clinical Minute
MIGS for Severe and Refractory Glaucoma

Get access to Eyetube''s video library
Register Now ?

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to Eyeflash Newsletter from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

NEW EPISODE | April 22, 2020

Video

WATCH THIS WEEK''S EPISODE

IN THIS EPISODE

BMC to Host First Virtual Spring Symposium in May

CMS Releases New Guidance on Restarting Elective Procedures

AAO Addresses Reopening of Ophthalmology Care

Ophthalmic Companies Devote Resources to Assist Eye Care Professionals and Patients During COVID-19

VIEW ALL SEGMENTS

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Editorially independent content supported with advertising.

Managing a Torn and Dislocated IOL

One week after a patient received a secondary IOL, she reported blurry vision, and the IOL was found to be dislocated and torn. How did Beeran B. Meghpara, MD, handle the case?

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

THE TOP THREE ARTICLES YOU SHOULD BE READING:

1	Patient Pointers for Ocular Photography By John A. Hovanesian, MD, FACS As the COVID-19 outbreak pushes ophthalmologists to conduct virtual consultations, patients' ability to capture anterior segment photographs with their smartphones has become important. Check out some tips to share with them.
2	The Role of Statins in Glaucoma Treatment By Ahmad A. Aref, MD, MBA Catch up on the evidence suggesting that these agents are protective.
3	Ten Tips for Graduating Glaucoma Fellows By Michael Lin, MD; Ayan Chatterjee, MD, MSEd; Jonathan Chou, MD; Haben Kefella, MD; Stephen Moster, MD; Mary Qiu, MD; Aakriti Garg Shukla, MD; David Smits, MD; Swarup Swaminathan, MD; Astrid Werner, MD; and Cindy Zheng, MD Get advice on your upcoming transition from attendings who started practice this past year.

SUPPLEMENT
Sponsored by Allergan

READ ON GlaucomaToday.COM ?

FEATURED VIDEO IN
GLAUCOMA

Combining Mechanisms: Viscodilation, Trabeculectomy, and Hydrus Implantation
Inder Paul Singh, MD


	WATCH NOW ON EYETUBE.NET

GLAUCOMA NEWS

05.18.20
AMA Issues Guidance to Physicians on Using COVID-19 Antibody Tests    READ MORE

05.18.20
EyePoint Pharmaceuticals Presents Data Showcasing Dexycu at the ASCRS Virtual Meeting    READ MORE

05.18.20
Sight Sciences Announces Positive Clinical Results From Trial Evaluating TearCare for the Treatment of Dry Eye Disease    READ MORE

RECENT Glaucoma Today ISSUES

stay updated on all things Glaucoma

click here

Advertise | Submit Breaking News | Contact Us

* Free print subscriptions are available to practicing physicians in the US.
All others, applicable subscription charges apply.

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.

You received this email because you are subscribed to Glaucoma Today Newsletter from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us | Legal Disclaimer

TOP STORY OF THE WEEK
Market Scope: Premium IOL Volume Faces Challenges in Rebounding Post-COVID ?

TRENDING NEWS
06.08.20
Novartis Provides Update On Use and Safety of Beovu (Brolucizumab) ?

06.12.20
Johnson & Johnson Vision Presents Myopia Research Findings at ARVO ?

06.11.20
US Hits 2 Million Coronavirus Cases As Many States See A Surge Of Patients ?

06.11.20
Modernizing Medicine Introduces Modmed SynapSYS Development Platform ?

06.09.20
Vasoptic Medical Receives FDA 510(k) Clearance for Retinal Imaging Device ?

06.09.20
Eversight Awarded Targeted Research Grant to Analyze COVID-19 Effects on Eye Donation ?

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

NEW ISSUE | MAY 2020

The latest issue of CRST Europe celebrates the shrinking of the gender gap in ophthalmology and considers the challenges that remain.

READ MAY ISSUE

THE TOP THREE ARTICLES YOU SHOULD BE READING:

1	The Gender Gap By Lisa Brothers Arbisser, MD; Allon Barsam, MD, MA, FRCOphth; Bj?rn Johansson, MD, PhD, FEBO; A. John Kanellopoulos, MD; Aylin Kili?, MD; Marguerite B. McDonald, MD, FACS; Magda Rau, MD; Marie-Jos? Tassignon, MD, PhD, FEBO, FEBOS-CR; Denise M. Visco, MD, MBA Get candid insight into progress toward gender equity in ophthalmology and hear from both genders how to influence further advances.
2	Cases That Have Stuck With Me By Allon Barsam, MD, MA, FRCOphth; Mark Kontos, MD; Soosan Jacob, MD, FRCS, DNB; Michael E. Snyder, MD; and Elizabeth Yeu, MD Five ophthalmologists share memorable cases. What did they learn from those experiences?
3	Early Presbyopia in a Patient With High Hyperopia By Romesh Angunawela, BM, MD, FRCOphth, FRCS, Cert LRS; Gilles Lesieur, MD; Tal Raviv, MD; and Pavel Stodulka, MD, PhD What are the surgical options for this patient who desires independence from spectacles and contact lenses?

Also in This Issue

Preoperative Corneal Marking for Toric IOL Implantation ?

Small Pupil, Dense Lens, Severe Zonulopathy ?

Graftless Corneal Endothelial Replacement ?

READ MAY ISSUE ?

FEATURED VIDEO IN
CATARACT

Diagonal Haptics Capture of Anterior Rhexis in Compromised Posterior Capsule
Lukan Mishev, MD


	WATCH NOW ON EYETUBE.NET

CATARACT & REFRACTIVE NEWS

05.22.20
A New Artificial Eye Mimics and May Outperform Human Eyes    READ MORE

05.20.20
New Paper in Clinical and Experimental Optometry Summarizes SARS-CoV-2 Interaction With the Ocular Surface    READ MORE

05.19.20
Market Scope: Premium IOLs Expected to Drive Market Growth Over the Next 5 Years    READ MORE

RECENT CRST Europe ISSUES

stay updated on all things Cataract

click here

Advertise | Submit Breaking News | Contact Us

* Free print subscriptions are available to practicing physicians in the US.
All others, applicable subscription charges apply.

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.

You received this email because you are subscribed to Cataract & Refractive Surgery Today Europe Newsletter from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us | Legal Disclaimer

Editorially independent content supported with advertising.

Macula-off Retinal Detachment After Cataract Surgery

A 49-year-old woman with a history of cataract surgery experienced a macula-off retinal detachment. Upon examination, a giant retinal tear and several other retinal breaks were evident. How did Michael N. Cohen, MD, handle the case?

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

NEW EPISODE | April 29, 2020

Video

WATCH THIS WEEK''S EPISODE

IN THIS EPISODE

AAO, ASCRS, and OOSS Develop Checklist for Reopening Ophthalmic Surgery Centers

Experts Discuss Impact of COVID-19 On Residents and Training Programs

Ocular Therapeutix Announces Phase 3 Data of Dextenza for Allergic Conjunctivitis

New Dates Announced for BMC Virtual Spring Symposium

VIEW ALL SEGMENTS

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

NEW EPISODE | May 20, 2020

Video

WATCH THIS WEEK''S EPISODE

IN THIS EPISODE

Alcon ARGOS Biometer With Image Guidance Now Widely Available in the US

Johnson & Johnson Vision Announces US Launch of the Tecnis Multifocal Toric II IOL

Avellino''s ACTS Program to Help Protect Patients and Staff From COVID-19

Ocutrx Unveils OR-Bot Surgery Visualization Theatre

BVI Acquires Ophthalmic Viscoelastic Device Assets From Croma

VIEW ALL SEGMENTS

Advertise | Send a Tip or Event | Contact Us

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

TOP STORY OF THE WEEK
Study: Dexamethasone Reduces Death In Hospitalized Patients With Severe Respiratory Complications of COVID-19 ?

TRENDING NEWS
06.15.20
Iveric Bio Announces Positive Zimura 18-Month Data Supporting the 12-Month Efficacy Findings for GA Secondary to AMD ?

06.19.20
Viela Bio Announces FDA Approval of Uplinza (Inebilizumab) for the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) ?

06.15.20
FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine ?

06.19.20
Lineage Cell Therapeutics Reinitiates Patient Enrollment in Clinical Study of OpRegen for the Treatment of Dry AMD With GA ?

06.16.20
Bionic Sight Doses First Patient in a Phase 1/2 Clinical Trial of a New Investigational Treatment for Retinitis Pigmentosa ?

06.18.20
Santen and Orbis International Join Forces to Expand Access to Training for Eye Care Professionals Through Telemedicine Platform ?

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

YOUR RUNDOWN

Does COVID-19 affect the retina?
A small study published in The Lancet suggests that it does.

Tell me about the study.
Researchers used OCT to evaluate patients infected with SARS-CoV-2 to determine whether subclinical retinal changes were present. A total of 12 patients were examined 11 to 33 days after the onset of symptoms. All patients had normal blood parameters at the time of their eye exam.

What did they find?
All patients showed hyperreflective lesions at the level of ganglion cell and inner plexiform layers, more prominently at the papillomacular bundle in both eyes. Also of note, four patients presented with subtle cotton wool spots and microhemorrhages along the retinal arcade. The researchers noted that visual acuity and pupillary reflexes were normal in all eyes and that no symptoms or signs of intraocular inflammation were detected.

The take home:
The study authors stated that although COVID-19 animal models suggest that ocular lesions could include retinitis and optic neuritis, this is, to the best of their knowledge, the first report of retinal findings possibly associated with COVID-19 infection in humans.

WHAT YOUR PATIENT MIGHT ASK YOU

Are there any glasses that can prevent my myopia from getting worse?
There''s a new option-if you live in the European Union (EU). SightGlass Vision received approval to commercialize its new product in the EU, United Kingdom, and other European Economic Area countries.

What is the new product?
It''s a spectacle lens made with the company's Diffusion Optics Technology and is designed to lower contrast in a focus-independent manner while still providing excellent visual acuity. This works under the hypothesis that high retinal contrast causes myopia and therefore lowering retinal contrast would reduce the progression of myopia.

When can we get it in the United States?
TBD.

IN OTHER NEWS

Optometry practices looted.
After weeks of being closed down due to COVID-19, most optometry practices had finally started to reopen by the end of May. Unfortunately, many practices in several cities across the nation, already feeling a sense of hardship, were looted during protests over the death of George Floyd. ODs on Facebook organized a GoFundMe fundraiser to raise money for OD-owned independent practices damaged by looters during the protests. Donate if you can. Share if you're willing.

Black lives matter.
Of course there's a bigger issue outside of the looting, and it's part of the reason for the protests: racism. Below are some organizations you can support that serve the black community.
. The NAACP Legal Defense and Educational Fund: America's premier legal organization fighting for racial justice through litigation, advocacy, and public education.
. Advancement Project: A multi-racial civil rights organization that uses innovative tools and strategies to strengthen social movements and achieve high impact policy change.

SOCIAL MEDIA ROUNDUP

89%
The number of practices surveyed that now incorporate telehealth care. (via)

You''re not the only one with money problems.
Vision Group Holdings, the management company behind TLC and Lasik Vision Institute, has filed for bankruptcy. (via)

See you next week!

Jackie Garlich OD, FAAO
Editor & Founder // 20/20 Glance

Enjoy this email? Tell your friends to sign up here!

Have news or a comment to share?

send me an email!

Email Me // About

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to 20/20 Glance Newsletter from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

NEW EPISODE | July 1, 2020

Video

WATCH THIS WEEK''S EPISODE

IN THIS EPISODE

The FDA Does Not Approve AbbVie's Wet AMD Drug Candidate Abicipar Pegol

Eye Care Experts Participate In the First AECOS Virtual Summer Symposium

Executives Discuss Impact of COVID-19 on Ophthalmic Industry

Novartis Withdraws Marketing Application of Dry Eye Drug Xiidra in Europe

VIEW ALL SEGMENTS

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

The AECOS Summer Series

June 25 - August 1, 2020

Live Webinar Series

Register Today!

Program Chairs

Francesco
Carones, MD

Sheraz M.
Daya, MD

Steven J.
Dell, MD

William J.
Link, PhD

Erik
Mertens,MD

William B.
Trattler, MD

Agenda

AECOS Europe Series

Saturday, July 18 | 16:00 - 18:00 Central European Time | (9:00 - 11:00 AM Central Daylight Time)

Artificial Intelligence

Moderator: Damien Gatinel MD
Faculty: Dimitri Azar MD, Aylin Kilic MD
Topics:

Jos Rozema, PhD | Artificial Intelligence / Machine Learning in Ophthalmology
Ranya Habash, MD | Artificial Intelligence - Successes and Pitfalls
Malvina Eydelman, MD | Regulatory issues in AI

Presbyopia

Moderators: Sheraz Daya MD, Florian Kretz MD
Faculty: Detlev Breyer MD, Susana Marcos PhD, Michael Mrochen PhD
Topics:

Sheraz Daya, MD | Introductory Talk: Fractured terminology for Presbyopia correcting lenses
Florian Kretz, MD | Lens 1: Trifocals and EDOF Lenses
TBD | Lens 2: Small aperture lenses
Susana Marcos, PhD | Lens 3: Enhanced Monofocal
Detlev Breyer, MD | Lens 4: Accommodative Lenses

Saturday, July 25 | 16:00 - 18:00 Central European Time | (9:00 - 11:00 AM Central Daylight Time)

Breaking News

Moderators: Arthur Cummings MD, Burkhard Dick MD
Topics:

Gerd Auffarth, MD | EyeYon Artificial DMEK Implant
Alfredo Ruggeri, MD | Quantum Molecular Resonance
Davide Borroni, MD | Metagenomics
Tara Moore, PhD | Genetic Engineering
Jorge Alio, MD| Neural Network AI to Guide Treatment of Keratoconus by ICRS

Refractive Revival: What Patients Need and Want Post COVID-19

Moderator: Erik Mertens MD
Discussants: Gerd Auffarth MD, Francesco Carones MD, Matt Jensen, Shareef Mahdavi
Topics:

Dan Reinstein, MD | What worries me...
Stefanie Schmickler, MD | What worries me...
Amanda Carones | How do we bounce back?

AECOS Ophthalmic Innovation Forum

Saturday, August 1 | 10:00 AM - 12:00 PM Central Daylight Time

Moderator: William Link PhD
Faculty: Andy Corley, Richard Lindstrom MD
Companies:

Intelon | Richard Lindstrom MD
LENSAR GEN 2 | Nick Curtis
AcuFocus | Yari Mitchell
RxSight | Ron Kurtz MD
Equinox | Matt Larson
TearClear | Robert Dempsey
Tarsus Rx | Bobak Azamian MD
Oyster Point Pharma | Jeffrey Nau PhD

Register Today!

View email in your browser

This sponsored message helps support the free educational content produced by Bryn Mawr Communications LLC.

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to BMC Group from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

FEATURED NEWS STORY
Forecasting the New Normal: Experts Across Eye Care Discuss COVID-19's Impact
On a recent episode of Ophthalmology Off the Grid, cohosts Gary W?rtz, MD, and Blake Williamson, MD, MPH, were joined by Iqbal Ike K. Ahmed, MD, FRCSC; John Kitchens, MD; and Justin Schweitzer, OD, to discuss COVID-19's impact across eye care and share their predictions for how the current situation will alter the future of their areas of expertise.
VIEW STORY ?

OTHER COVID-19 NEWS
04.23.20
FDA Authorizes First Test for Patient At-Home Sample Collection
The FDA has authorized the first diagnostic test with a home collection option for COVID-19. LabCorp's COVID-19 RT-PCR test allows testing of samples self-collected by patients at home using the company''s Pixel COVID-19 home collection kit.
VIEW STORY ?

04.23.20
How Meeting Cancellations Have Affected the Optometric Profession and Industry
On a recent episode of The MOD Pod, Jessilin Quint, OD, FAAO, and Frank Won, OD, speak with Jason R. Miller, OD, FAAO; Emilie Seitz; and Walter O. Whitley, OD FAAO, about how meeting cancellations have affected the optometric profession, how ODs are fulfilling their CE credit requirements, and how optometry students are coping with distance learning.
VIEW STORY ?

VIEW ALL COVID-19 COVERAGE

This resource has been made possible with support from our industry sponsors

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

NEW ISSUE | May/June 2020

This issue of Glaucoma Today describes the impact that MIGS is having on the field.

READ May/June ISSUE

THE TOP THREE ARTICLES YOU SHOULD BE READING:

1	Memorable MIGS Cases By Won I. Kim, MD; Mazeyar Saboori, MD; Monisha M. Vora, MD; H. George Tanaka, MD; Bac T. Nguyen, MD; I. Paul Singh, MD; and Lorraine M. Provencher, MD Explore the value of microinvasive glaucoma surgery through scenarios presented by several surgeons.
2	Highlights of the 2020 AGS Annual Meeting By Geoffrey T. Emerick, MD Catch up on the results from clinical trials and research studies that were presented at the 30th annual meeting of the American Glaucoma Society this spring.
3	Pearls and Practices for Virtual Eye Care By Sophie D. Liao, MD; Eimi Rodriguez-Cruz, BS; Malik Y. Kahook, MD; and Cara E. Capitena Young, MD Get nine tips on how to harness virtual health to deliver the care your patients need.

Also in This Issue

Eye Care in the Era of COVID-19 ?

Crowdsourcing in Ophthalmology ?

Company Culture: The Secret Sauce for Success ?

READ May/June ISSUE ?

FEATURED VIDEO IN
GLAUCOMA

Chronic Hypotony Complicated With Filtration Bleb Rupture
Frederic Aissani, MD


	WATCH NOW ON EYETUBE.NET

GLAUCOMA NEWS

06.19.20
Providers to Congress: Patients Will Lose Access to Care Without Permanent Expansion of Telehealth    READ MORE

06.18.20
Federation of American Hospitals Demands More Time for Providers to Repay Advance Medicare Payments Due Soon    READ MORE

06.16.20
Study: Dexamethasone Reduces Death in Hospitalized Patients With Severe Respiratory Complications of COVID-19    READ MORE

RECENT Glaucoma Today ISSUES

stay updated on all things Glaucoma

click here

Advertise | Submit Breaking News | Contact Us

* Free print subscriptions are available to practicing physicians in the US.
All others, applicable subscription charges apply.

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.

You received this email because you are subscribed to Glaucoma Today Newsletter from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us | Legal Disclaimer

FEATURED NEWS STORY
New Dates Announced for BMC Virtual Spring Symposium
Bryn Mawr Communications (BMC) has announced that its first virtual educational initiative, the BMC Virtual Spring Symposium, will now be held on May 29-30. The BMC Virtual Spring Symposium is designed to enable discussion, engagement, and live Q&A for members of the vision community while the traditional meeting schedule remains compromised due to COVID-19.
VIEW STORY ?

OTHER COVID-19 NEWS
04.24.20
How Will the COVID-19 Crisis Transform Retina Care in Europe
With Jordi Mon?s, MD, PhD (Spain) at the helm, New Retina Radio asks David H.W. Steel, MBBS, FRCOphth (United Kingdom); Murat Oncel, MD (Turkey); and Armin Wolf, MD, FEBO (Germany), how the COVID-19 crisis will transform retina care in Europe?
VIEW STORY ?

04.27.20
CMS Reevaluates Accelerated Payment Program and Suspends Advance Payment Program
CMS will not be accepting any new applications for the Advance Payment Program, and will be reevaluating all pending and new applications for Accelerated Payments in light of historical direct payments made available through the Department of Health & Human Services' (HHS) Provider Relief Fund.
VIEW STORY ?

VIEW ALL COVID-19 COVERAGE

This resource has been made possible with support from our industry sponsors

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

FEATURED NEWS STORY
Market Scope: Premium IOL Volume Faces Challenges in Rebounding Post-COVID
Results from Part 1 of Market Scope's "COVID-19 US Practice Impact Survey" reveal that nearly 41 percent of surgeons expect a decrease in premium IOL conversion once COVID-19 subsides. These surgeons expect an average decrease of 34 percent, and most respondents believe that financial concerns would be the primary driver of this decrease.
VIEW STORY ?

OTHER COVID-19 NEWS
06.081.20
Phosphorus Announces FDA Approval Of At-Home Saliva Test for COVID-19
Phosphorus announced that the FDA granted the Emergency Use Authorization request for its saliva test for COVID-19 that features at-home sample collection. The test is available by ordering online, as well as through health care and employer partnerships aimed at safely resuming operations. This is only the second at-home unsupervised saliva test approved so far by the FDA.
VIEW STORY ?

06.08.20
New York Times: Hospitals Got Bailouts and Furloughed Thousands While Paying CEOs Millions
The New York Times analyzed tax and securities filings by 60 of the country's largest hospital chains, which have received a total of more than $15 billion in emergency funds through the economic stimulus package in the federal CARES Act. The hospitals are collectively sitting on tens of billions of dollars of cash reserves that are supposed to help them weather an unanticipated storm.
VIEW STORY ?

VIEW ALL COVID-19 COVERAGE

This resource has been made possible with support from our industry sponsors

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

NEW EPISODE | May 6, 2020

Video

WATCH THIS WEEK''S EPISODE

IN THIS EPISODE

AAO Surveys Reveal the Effect COVID-19 is Having On Ophthalmology Practices

Leaders of Ophthalmic Medical Societies Provide Updates on Annual Meetings

The FDA Issues an Emergency Use Authorization For Potential COVID-19 Treatment

Kala Pharmaceuticals Resubmits NDA For Dry Eye Drug Candidate Eysuvis

VIEW ALL SEGMENTS

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

NEW EPISODE | May 13, 2020

Video

WATCH THIS WEEK''S EPISODE

IN THIS EPISODE

COVID-19 Analysis: Ophthalmology Lost More Patient Volume Than Any Other Specialty

FDA Approves Quidel's Sofia 2, First Antigen Test to Help in the Detection of COVID-19

AbbVie Completes $63 Billion Acquisition of Allergan

Sight Sciences Introduces the Next-Generation Omni Surgical System for MIGS

Oyster Point Announces Phase 3 Trial Results of Nasal Spray for Dry Eye Disease

VIEW ALL SEGMENTS

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

FEATURED NEWS STORY
AAO Calls on Health Plans to Suspend Prior Authorization and Step Therapy
The American Academy of Ophthalmology this week published an open letter to all health plans, calling for the suspension of regulatory barriers, specifically prior authorization and step therapy, for both COVID-19 and non-COVID-19-related services until the health care delivery system returns to normalcy.
VIEW STORY ?

OTHER COVID-19 NEWS
05.13.20
ASRS Announces Virtual Annual Scientific Meeting July 24-26, 2020
Due to the COVID-19 pandemic, the American Society of Retina Specialists (ASRS) has decided to hold its annual meeting online. In a letter to membership, Timothy Murray, MD, MBA, ASRS President, and Philip Ferrone, MD, Program Chair, said the live streaming portion of this event will start the evening of Friday, July 24 and end the afternoon of Sunday, July 26.
VIEW STORY ?

05.14.20
What Technologies Will Endure After the COVID-19 Pandemic Subsides?
New Retina Radio host John Kitchens, MD, is joined by Caroline Baumal, MD; Mar?a Berrocal, MD; and Judy Kim, MD, to discuss which practices will be rolled into modern protocols, which technologies on the horizon may have greater value in a post-COVID world, and how treatment decisions have (or have not) been adjusted to face today's unique challenges.
VIEW STORY ?

VIEW ALL COVID-19 COVERAGE

This resource has been made possible with support from our industry sponsors

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

Editorially Independent Podcast, Supported With Advertising

Telemedicine for Dry Eye Care

Ranya Habash, MD; and William Trattler, MD, join Marguerite McDonald, MD, FACS, to discuss using telemedicine for dry eye patients.

LISTEN NOW

Listen to Recent Episodes
Episode 28 Providing Patients With Customized Care	Episode 27 The Growing Femtosecond Market

How to Listen
Subscribe on Apple or Android to have each new episode automatically downloaded to your device, stream each episode on-demand on Eyetube, or use any podcast manager.

Subscribe to Informed Consent:

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to Informed Consent from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

FEATURED NEWS STORY
Insight Into FDA's Revised Policy on Antibody Tests: Prioritizing Access and Accuracy
In a blog post on the FDA website, agency leaders outlined a new policy that aims to provide more oversight of COVID-19 antibody tests. The revised policy on antibody tests was written by Anand Shah, MD, Deputy Commissioner for Medical and Scientific Affairs, and Jeff Shuren, MD, Director, Center for Devices and Radiological Health.
VIEW STORY ?

OTHER COVID-19 NEWS
05.06.20
Experts Discuss Telemedicine's Viability and Durability During COVID-19
New Retina Radio host John Kitchens, MD, talks with S.K. Steven Houston III, MD; John B. Miller, MD; and Ehsan Rahimy, MD, to understand telemedicine's viability and durability during and beyond the COVID-19 era, and to review proper coding tactics to ensure compliance.
VIEW STORY ?

05.07.20
CooperVision Offers Complimentary Contact Lenses for Hospital Workers on Front Lines of COVID-19 Pandemic
In support of essential hospital workers fighting on the front lines of the COVID-19 pandemic, CooperVision said it will provide US eye care professionals with complimentary contact lens refills. Through the program, essential hospital workers may receive one box of CooperVision contact lenses for each eye, including all 1-day, 2-week, and monthly brands that the company manufactures.
VIEW STORY ?

VIEW ALL COVID-19 COVERAGE

This resource has been made possible with support from our industry sponsors

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

FEATURED NEWS STORY
FDA Approves Quidel's Sofia 2, First Antigen Test to Help in the Rapid Detection of COVID-19
Quidel, maker of diagnostic tests for a variety of conditions including acute conjunctivitis and dry eye disease, announced that it has received Emergency Use Authorization (EUA) from the FDA to market its Sofia 2 SARS Antigen FIA, a rapid point-of-care test for the detection of COVID-19. Sofia 2 is the first antigen test approved by the FDA, a new category of tests for use in the ongoing pandemic.
VIEW STORY ?

OTHER COVID-19 NEWS
05.11.20
Analysis: Ophthalmology Lost More Patient Volume Due to COVID-19 Than Any Other Specialty
The analysis of over 2 million patient visits and encounters from 228 hospitals in 40 states by Strata Decision Technology showed that ophthalmology lost 81% of patient volume year-over-year when comparing 2-week volumes in March and April 2020 vs the same period in 2019. During the same period, it also found a 97% reduction in cataract surgery volume-the largest reduction of any surgical procedure-and an 88% reduction in glaucoma procedures.
VIEW STORY ?

05.08.20
Retina-Focused Societies Around the World Provide Guidance to Their Members
New Retina Radio special guest host and president of the Retina World Congress Tarek Hassan, MD (United States), sits down with Asia-Pacific VitreoRetina Society leadership member Paisan Ruamviboonsuk, MD (Thailand), and Pan-American Association of Ophthalmology Immediate Past-President J. Fernando Arevalo, MD, PhD (United States), and Euretina General Secretary Anat Loewenstein, MD (Israel).
VIEW STORY ?

VIEW ALL COVID-19 COVERAGE

This resource has been made possible with support from our industry sponsors

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

TOP STORY OF THE WEEK
Can Ophthalmic Clinical Trials Proceed During COVID-19 Crisis? ?

TRENDING NEWS
04.27.20
CMS Reevaluates Accelerated Payment Program and Suspends Advance Payment Program ?

05.01.20
Gilead 'Moving Very Quickly' With FDA on Possible Coronavirus Use, CEO Says ?

04.30.20
Quest, LabCorp Launch Nationwide COVID-19 Antibody Testing in Pharmacies and Online ?

04.27.20
New Dates Announced for BMC Virtual Spring Symposium ?

04.29.20
COVID-19: Finding Opportunity in Crisis ?

04.28.20
Sanofi/Regeneron and Roche Report Mixed Results for Potential COVID-19 Treatments ?

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

Editorially independent content supported with advertising.

Clinical Trial Data on a Fixed Combination of Netarsudil and Latanoprost

Ehsan Sadri, MD, and Neda Shamie, MD, discuss 3-month data from a randomized, double-masked, phase 3 clinical trial of a fixed combination of netarsudil and latanoprost. How did the fixed combination stack up against monotherapy with netarsudil or latanoprost?

CLICK HERE TO WATCH THE VIDEO

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

The AECOS Summer Series

June 25 - August 1, 2020

Live Webinar Series

Register Today!

Program Chairs

Francesco
Carones, MD

Sheraz M.
Daya, MD

Steven J.
Dell, MD

William J.
Link, PhD

Erik
Mertens,MD

William B.
Trattler, MD

Agenda

AECOS America Series

Thursday, June 25 | 7:00 - 8:30 PM Central Daylight Time

Practice Impossible
AECOS Industry Panel

Thursday, July 9 | 7:00 - 8:30 PM Central Daylight Time

AECOS Clinical Case Presentations
Medical Legal issues

AECOS Europe Series

Saturday, July 18 | 16:00 - 18:00 Central European Time | (9:00 - 11:00 AM Central Daylight Time)

Artificial Intelligence
Presbyopia

Saturday, July 25 | 16:00 - 18:00 Central European Time | (9:00 - 11:00 AM Central Daylight Time)

Breaking News
Refractive Revival: What Patients Need and Want Post COVID-19

AECOS Ophthalmic Innovation Forum

Saturday, August 1 | 10:00 AM - 12:00 PM Central Daylight Time

Register Today!

View email in your browser

This sponsored message helps support the free educational content produced by Bryn Mawr Communications LLC.

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to Bio-Tissue from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

TOP STORY OF THE WEEK
Survey: Use of Virtual Education Soars; Telemedicine Remains a Small Percentage of Volume ?

TRENDING NEWS
06.26.20
The FDA Does Not Approve Allergan's Wet AMD Drug Candidate Abicipar Pegol ?

06.22.20
Johnson & Johnson Vision Receives FDA Clearance for Catalys cOS 6.0 Software for Astigmatism Management ?

06.26.20
2021 ASCRS Annual Meeting Pushed Back to August ?

06.25.20
Topcon Announces the European Launch of MYAH Management Tool for Myopia and Dry Eye ?

06.26.20
DORC Launches New Range of EVA EquiPhaco Needles and Sleeves ?

06.25.20
Visual Clinic's Patient Flow Management Solution Aims to Help Eye Care Clinics Operate Post-COVID-19 ?

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

Join NIDEK IMAGE OF THE YEAR AWARD 2020

"invisible to visible" new findings with Mirante

Grand Prix submission will be featured on Retina Today published by BMC Vision. Get your imaging expertise published in the RT journal!

Submission Deadline: August 20th, 2020

If you have any questions, please feel free to contact NIDEK at marketing@nidek.co.jp

Scanning Laser Ophthalmoscope
Mirante

The Ultimate Multimodal Imaging Platform

NOTE: The availability of the products differs from country to country depending on the status of approval in each country. Please contact our distributor in your country for the precise information.>>Distributor Search Specifications and design are subject to change without notice.

NIDEK CO., LTD. 34-14 Maehama, Hiroishi-cho, Gamagori, Aichi 443-0038, Japan E-mail: marketing@nidek.co.jp Website: www.nidek-intl.com

View email in your browser

This sponsored message helps support the free educational content produced by Bryn Mawr Communications LLC.

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to Nidek from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

Editorially Independent Podcast, Supported With Advertising

The Value of Laser Cataract Surgery and Toric IOLs

Kendall Donaldson, MD, MS; Preeya Gupta, MD; and Marguerite McDonald, MD, FACS, tackle how to explain the value of laser cataract surgery and toric IOLs to patients who have astigmatism.

LISTEN NOW

Listen to Recent Episodes
Episode 29 Telemedicine for Dry Eye Care	Episode 28 Providing Patients With Customized Care

How to Listen
Subscribe on Apple or Android to have each new episode automatically downloaded to your device, stream each episode on-demand on Eyetube, or use any podcast manager.

Subscribe to Informed Consent:

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to Informed Consent from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

TOP STORY OF THE WEEK
CMS Releases Guidance for How Health Systems Can Restart Elective Procedures ?

TRENDING NEWS
04.17.20
Forecasting the New Normal: Experts Across Eye Care Discuss COVID-19's Impact ?

04.16.20
AAO Survey Reveals Pandemic's Effect on Private Ophthalmic Practices ?

04.16.20
COVID-19: The Impact on Training Programs ?

04.14.20
Ambulatory Surgery Centers Eligible For New Relief Grant Funds ?

04.17.20
FDA Authorizes First Test for Patient At-Home Sample Collection ?

04.17.20
COVID-19: Fellowship and Training in Flux ?

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

An Amazing Tool for Toric IOLs

From seamless transfer of pre-op diagnostics to IntelliAxis Refractive Capsulorhexis^?, the LENSAR^? Laser provides Audrey Talley Rostov, MD, with tools for confident axis placement and accurate toric IOL alignment.

Watch the video ?

A Necessity for All Advanced IOL Procedures

Dr. Rostov shares why the LENSAR Laser System should be part of any advanced IOL procedure.

Watch the video

Making Complex Cases Routine

Even in the most complex cases, the LENSAR Laser guides Dr. Rostov to deliver the best possible outcomes for all of her cataract patients.

Watch the video

See what other leading experts are saying about LENSAR's evolved advantages.

View All Videos ?

? 2020 LENSAR, Inc. All rights reserved. LENSAR, the LENSAR logo, the LENSAR Cataract Laser With Augmented Reality logo, and IntelliAxis Refractive Capsulorhexis are registered trademarks of LENSAR, Inc. 50-00276-000 Rev A 03/20

View email in your browser

This sponsored message helps support the free educational content produced by Bryn Mawr Communications LLC.

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to Lensar from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

Sponsored by Topcon Healthcare

Refining the Use of OCT in Diagnosing Glaucoma

	"The DRI OCT Triton (Topcon) is equipped with the Active Eye Tracking feature for use during angiography...the device is capable of 100,000 A-scans/sec-more than double that of SD-OCT-which reduces the impact of microsaccades."
	Ki Ho Park, MD, PhD

In this insert, Ki Ho Park, MD, PhD, discusses common operator and clinician errors that can lead to misinterpretation of OCT images used to evaluate patients with suspected glaucoma. He reviews how the use of the swept-source OCT (SS-OCT) DRI OCT Triton (Topcon) complements his evaluations and combats some of those errors. He also emphasizes how swept-source technology improves the ability to diagnose glaucoma compared to spectral-domain (SD-OCT) technology.

read Insert

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to Supplements from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

FEATURED NEWS STORY
FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine
The FDA revoked the emergency use authorization (EUA) that allowed for chloroquine and hydroxychloroquine to be used to treat certain hospitalized patients with COVID-19. Based on its ongoing analysis of the EUA and emerging scientific data, the FDA determined that chloroquine and hydroxychloroquine are "unlikely to be effective in treating COVID-19 for the authorized uses in the EUA."
VIEW STORY ?

OTHER COVID-19 NEWS
06.15.20
Orbis International Launches Virtual Flying Eye Hospital Training Programs
Orbis International launched virtual Flying Eye Hospital training programs through its telemedicine platform, Cybersight, which provides online training and mentorship for eye care professionals in low- and middle-income countries. The inaugural program has been designed for eye care professionals in Zambia who were due to receive in-person training on board the Flying Eye Hospital last month.
VIEW STORY ?

06.15.20
AstraZeneca to Supply Europe Up to 400 Million COVID-19 Vaccine Doses
AstraZeneca announced that it has reached an agreement with Europe's Inclusive Vaccines Alliance (IVA) to supply up to 400 million doses of the University of Oxford's COVID-19 experimental vaccine, with deliveries starting by the end of this year.
VIEW STORY ?

VIEW ALL COVID-19 COVERAGE

This resource has been made possible with support from our industry sponsors

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

TOP STORY OF THE WEEK
Novartis Withdraws Marketing Application of Dry Eye Drug Xiidra in Europe ?

TRENDING NEWS
06.30.20
Iveric bio Announces First Patient Dosed in Second Zimura Phase 3 Trial for Treatment of GA ?

07.02.20
Quantel Medical Completes Acquisition of Ellex ?

06.30.20
After Sale of Ellex Medical Lasers, Nova Eye Medical is Formed ?

06.30.20
Samsung Bioepis Initiates Phase 3 Clinical Trial for SB15, Proposed Biosimilar to Eylea (Aflibercept) ?

06.29.20
Coburn Technologies Announces the New Velocity LTE Spin Coating System ?

06.30.20
OcuBlink Introduces Synthetic Eyeballs for AR/VR Testing ?

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

Editorially independent content supported with advertising.

Satisfaction After Refractive Lens Exchange Using an Extended Depth of Focus IOL

Steven Schallhorn, MD, joins Neda Shamie, MD, to discuss a 3-month study of postoperative satisfaction with refractive lens exchange using an extended depth of focus IOL. Which independent factors were predictive of patients' satisfaction?

CLICK HERE TO WATCH THE VIDEO

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.


What''s New to Eyetube.net: June 2020

Aerosol During Phacoemulsification: How to Make Cataract Surgery Safe During COVID-19

by Asaf Achiron, MD; Derek Tole, MD; Duncan Leadbetter, MD; Johan Keller, MD; Kieren Darcy, MD; Omar El-Haddad, MD; and Sidath Liyanage, MD

Asaf Achiron, MD, and colleagues conduct a series of experiments investigating aerosol production during cataract surgery. Get some helpful tips on reducing potential risk during the COVID-19 pandemic.
Watch Now >

Traumatic Iridodialysis and Cyclodialysis Repair in a Phakic Child

by Ahmed Sallam, MD; Brita Rook, MD; and Riley Sanders, MD

Ahmed Sallam, MD; Brita Rook, MD; and Riley Sanders, MD, present a case of a young patient with traumatic iridodialysis and cyclodialysis as well as worsening hyopotony maculopathy. How did they approach surgical repair while preserving the crystalline lens?
Watch Now >

An Update on My Modifications of the Yamane Technique: a Stepwise Approach

by D. Brian Kim, MD

D. Brian Kim, MD, describes how he has modified the Yamane technique to make it easier and more reliable and provide better outcomes.
Watch Now >

[3D Video] MX60 enVista Secondary IOL Scleral Fixation

by Aleksandra Rachitskaya, MD

Aleksandra Rachitskaya, MD, demonstrates the scleral fixation of a secondary IOL using an MX60 enVista lens (Bausch + Lomb) and Gore-Tex sutures.
Watch Now >

Chronic Hypotony Complicated With Filtration Bleb Rupture

by Frederic Aissani, MD

Frederic Aissani, MD, describes how he managed the case of a 62-year-old patient who experienced chronic hypotony 5 years after undergoing a nonpenetrating deep sclerectomy.
Watch Now >

Other Series:

Ophthalmology off the Grid
Survive & Thrive: The Transition to Practice

Informed Consent
The Value of Laser Cataract Surgery and Toric IOLs

Clinical Minute
Outcomes With EDOF IOLs After Laser Refractive Surgery

MIGS Unplugged
Educating the Next Generation of Surgeons

Get access to Eyetube''s video library
Register Now ?

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to Eyeflash Newsletter from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

Editorially Independent Podcast, Supported With Advertising

The Benefits of Premium-Channel IOLs

William Wiley, MD; Brandon Ayres, MD; and John Berdahl, MD, join Marguerite McDonald, MD, FACS, to share how they explain the benefits of premium-channel IOLs to patients.

LISTEN NOW

Listen to Recent Episodes
Episode 30 The Value of Laser Cataract Surgery and Toric IOLs	Episode 29 Telemedicine for Dry Eye Care

How to Listen
Subscribe on Apple or Android to have each new episode automatically downloaded to your device, stream each episode on-demand on Eyetube, or use any podcast manager.

Subscribe to Informed Consent

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to Informed Consent from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

NEW EPISODE | June 10, 2020

Video

WATCH THIS WEEK''S EPISODE

IN THIS EPISODE

Market Scope Survey Examines Premium IOL Volume Post-COVID

BVI Launches CryoTreq for Treatment of Retinal Tears and Detachments

Bausch + Lomb Receives FDA Clearance for Infuse Daily Silicone Hydrogel Contact Lenses

VIEW ALL SEGMENTS

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

FEATURED NEWS STORY
CMS Reveals Number of People Who Signed Up for Coverage on HealthCare.gov During COVID-19
The Centers for Medicare & Medicaid Services (CMS) released a trends report that provides data on the number of individuals who signed up for coverage on HealthCare.gov through a special enrollment period (SEP) during the COVID-19 pandemic.
VIEW STORY ?

OTHER COVID-19 NEWS
06.30.20
Remdesivir, the First Coronavirus Drug, Gets a Price Tag
Remdesivir, the first drug shown to be effective against the coronavirus, will be distributed under an unusual agreement with the federal government that establishes nonnegotiable prices and prioritizes American patients, health officials announced on Monday.
VIEW STORY ?

06.30.20
Hospitals in New COVID-19 Hot Spots Face Delicate Balancing Act With Elective Surgeries
Some hospital systems located in states that are seeing huge spikes of COVID-19 are continuing to perform elective procedures and developing strategies to avoid a total shutdown.
VIEW STORY ?

VIEW ALL COVID-19 COVERAGE

This resource has been made possible with support from our industry sponsors

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

NEW EPISODE | June 3, 2020

Video

WATCH THIS WEEK''S EPISODE

IN THIS EPISODE

BMC Virtual Spring Symposium Brings Unique Perspective to Eye Care Community

Bausch + Lomb Announces European Launch of a New Platform of Preloaded IOLs

SightGlass Vision Granted CE Mark for Eyeglasses That Slow Myopia Progression in Children

In-Person ESCRS and Euretina Meetings Cancelled; Virtual Meetings Planned

VIEW ALL SEGMENTS

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Meeting Coverage From the 2020 AAO Virtual Cornea Subspecialty Day

Speakers from the meeting highlight key points of their presentations.

	The Future of Limbal Stem Cell Transplantation
In her review of limbal stem cell transplantation techniques and surgical outcomes, Ashiyana Nariani, MD, MPH, highlights recent scientific work aiming to address some of the issues associated with current standards of care. Among the advances are several modified versions of simple limbal epithelial transplantation and xenofree alternatives for culturing limbal epithelial stem cells.

	Predicting Graft Survival After PKP
Eric J. Shiuey, MS, reports on the use of a novel nomogram to predict graft survival after penetrating keratoplasty (PKP) and shares the top six variables with significant predictability of graft failure. Mr. Shiuey and colleagues at Wills Eye Hospital in Philadelphia conducted a study of more than 1,000 corneal transplants performed since 2007.

	A Deep-Learning Neural Network for Diagnosing Corneal Diseases
Use of a multi-disease, deep-learning neural network algorithm can simplify the diagnosis of common corneal diseases, Mohamed Abou Shousha, MD, FRCS, PhD, reports. He and researchers from Bascom Palmer Eye Institute in Miami developed a device to autonomously diagnose dry eye disease, keratoconus, and Fuchs endothelial dystrophy. In an independent validation study, their AI algorithm successfully classified 100% of Fuchs endothelial dystrophy, 97% of keratoconus, 90% of dry eye disease, and 92% of healthy eyes.

These programs are not affiliated with the official program of AAO 2020

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to Eyetube Meeting Coverage from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

FEATURED NEWS STORY
Regeneron Advances Double Antibody Cocktail Into Phase 3 COVID-19 Prevention Study
Regeneron Pharmaceuticals announced the start of a phase 3 study investigating the ability of the double antibody cocktail REGN-COV2 to prevent infection among uninfected people who have had close exposure to a COVID-19 patient.
VIEW STORY ?

OTHER COVID-19 NEWS
07.06.20
OraSure Technologies' Spit Test for COVID-19 is Coming Closer
A Pennsylvania technology company is racing to "democratize" testing for COVID-19, according to a Philadelphia Inquirer report. By September, Bethlehem's OraSure Technologies hopes to have a rapid, oral-fluid self-test on the market, one as quick and simple to use as those that can detect pregnancies.
VIEW STORY ?

07.06.20
Gilead's Veklury Gains Conditional EU Approval for Treatment of COVID-19
The European Commission granted conditional approval to Gilead Science''s Veklury (remdesivir) for the treatment of SARS-CoV-2 infection. The approval was supported by results from the ACTT trial, led by the US National Institute of Allergy and Infectious Diseases.
VIEW STORY ?

VIEW ALL COVID-19 COVERAGE

This resource has been made possible with support from our industry sponsors

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

FEATURED NEWS STORY
Vision Expo West 2020 Cancelled; Virtual Offerings Planned
The Vision Council and Reed Exhibitions, organizers of Vision Expo, announced the decision to cancel Vision Expo West 2020, scheduled to take place in Las Vegas from September 23-26. The Vision Council will be rolling out a series of virtual offerings to bring the optical community together in between the physical events.
VIEW STORY ?

OTHER COVID-19 NEWS
07.09.20
Gilead Begins Testing Inhaled Remdesivir for Outpatient Treatment of COVID-19
Gilead Sciences stated that it has initiated a phase 1a study testing an inhaled formulation of its COVID-19 treatment remdesivir for use in the outpatient setting. Remdesivir, currently administered intravenously through daily infusions, was authorized by the FDA for emergency use in early May to treat adult and paediatric patients who are in hospital with severe COVID-19 disease.
VIEW STORY ?

07.09.20
BD Launches 15-minute Coronavirus Antigen Test, Promises Millions in Coming Months
The FDA granted an emergency authorization to a portable coronavirus antigen test developed by BD, similar to a rapid flu test, designed to allow hospitals, doctors' offices, urgent care centers, and retail pharmacies to examine a person showing symptoms in about 15 minutes.
VIEW STORY ?

VIEW ALL COVID-19 COVERAGE

This resource has been made possible with support from our industry sponsors

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

NEW ISSUE | APRIL 2020

Get the latest information on correcting presbyopia and astigmatism with IOLs.

READ APRIL ISSUE

THE TOP THREE ARTICLES YOU SHOULD BE READING:

1	Lifestyle Match Index: Helping to Choose the Best IOL By Arthur B. Cummings, MB ChB, FCS(SA), MMed(Ophth), FRCS(Edin) Selecting the best IOL to meet the particular needs of a given patient is a daunting task. Learn how a Lifestyle Match Index (Vivior) can convert data on patients' visual behaviors and environments into useful clinical information.
2	Newcomers By Sheraz M. Daya, MD, FACP, FACS, FRCS(Ed), FRCOP; Rita Mencucci, MD; Robert Edward Ang, MD; H. Burkhard Dick, MD, PhD, FEBOS-CR; Pavel Stodulka, MD, PhD; Achraf Laouani, MD; Dany Salik, MD, FEBO; and Elie Motulsky, MD, PhD, FEBO; Khiun F. Tjia, MD; Tiago Monteiro, MD, FEBO, FEBOS-CR; Amir Hamid, BMedSci, BMBS, FRCOphth, CertLRS; Frank T. Kerkhoff, MD, PhD; Edoardo Ligabue, MD; and Mark Packer, MD Find out how some of the most recently released presbyopia-correcting and toric IOLs are performing in the real world.
3	Postoperative Management of Premium IOLs By Haytham Soliman, MD; Ahmad S. Alfaar, MD; Florian T.A. Kretz, MD, FEBO; and Alanna Nattis, DO, FAAO Are you prepared to deal with dislocated and malpositioned lenses?

Also in This Issue

Correcting Astigmatism in the Pseudophake ?

Risk Factors for Keratoconus Progression in Women ?

A Highly Demanding Patient ?

READ APRIL ISSUE ?

FEATURED VIDEO IN
CATARACT

Posterior Lamellar Keratoplasty and Dislocated IOL
Ozana Moraru, MD


	WATCH NOW ON EYETUBE.NET

CATARACT & REFRACTIVE NEWS

04.22.20
Q BioMed Initiates Rapid Development of Novel COVID-19 Therapeutics    READ MORE

04.21.20
Alexion to Investigate Effects of C5 Inhibition With Ultomiris in Hospitalized Patients With Severe COVID-19    READ MORE

04.21.20
Thirona Launches AI-Powered Solutions for COVID-19 Analysis on CT Scans    READ MORE

RECENT CRST Europe ISSUES

stay updated on all things Cataract

click here

Advertise | Submit Breaking News | Contact Us

* Free print subscriptions are available to practicing physicians in the US.
All others, applicable subscription charges apply.

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

You received this email because you are subscribed to Cataract & Refractive Surgery Today Europe Newsletter from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us | Legal Disclaimer

NEW ISSUE | March/April 2020

This issue explores how to empower patients with glaucoma to improve their care.

READ March/April ISSUE

THE TOP THREE ARTICLES YOU SHOULD BE READING:

1	A Systems-Based Approach to Patient-Centered Care By Paula Anne Newman-Casey, MD, MS Proper counseling is essential to patients' adherence, but physicians' time is scarce. How could a systems-based approach optimize patients' self-management skills and thus improve adherence?
2	Glaucoma in the Age of Patient-Reported Outcomes By Lorraine M. Provencher, MD Find out how patient-reported outcome measures can help capture the entire burden of disease.
3	Addressing Obstacles to Care By Michele C. Lim, MD Which psychosocial factors can impede success, and how can physicians remove these barriers?

Also in This Issue

Telemedicine in the Age of COVID-19 ?

The Case of the Creeping Paracentral Visual Field Defect ?

Ten Tips for Graduating Glaucoma Fellows ?

READ March/April ISSUE ?

FEATURED VIDEO IN
GLAUCOMA

Ahmed ClearPath Placement Using Small Incision and Taco Technique
Monisha M. Vora, MD


	WATCH NOW ON EYETUBE.NET

GLAUCOMA NEWS

04.23.20
In Sickest COVID-19 Patients, Underlying Conditions Are Common, Large Study Finds    READ MORE

04.23.20
FDA Authorizes First Test for Patient At-Home Sample Collection    READ MORE

04.22.20
HHS: Here's How Remaining $70B in COVID-19 Funding Will Be Distributed to Providers    READ MORE

RECENT Glaucoma Today ISSUES

stay updated on all things Glaucoma

click here

Advertise | Submit Breaking News | Contact Us

* Free print subscriptions are available to practicing physicians in the US.
All others, applicable subscription charges apply.

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

You received this email because you are subscribed to Glaucoma Today Newsletter from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us | Legal Disclaimer

FEATURED NEWS STORY
US Hits 2 Million Coronavirus Cases As Many States See A Surge Of Patients
The U.S. has reached another dire landmark in its fight against COVID-19, surpassing 2 million confirmed cases on Wednesday. New coronavirus infections are rising in at least 20 states, even as restrictions on daily life continue to ease across the country.
VIEW STORY ?

OTHER COVID-19 NEWS
06.10.20
Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate
Johnson & Johnson announced that through its Janssen Pharmaceutical division it has accelerated the initiation of the phase 1/2a first-in-human clinical trial of its investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant. Initially scheduled to begin in September, the trial is now expected to commence in the second half of July.
VIEW STORY ?

06.11.20
Study: Annual Costs for Diagnostic Tests Up to $25B, Antibody Tests Up to $19B
The estimated annual cost for diagnostic testing of COVID-19 will range from $6 billion to $25.1 billion, and the cost for antibody testing could vary from $5.2 billion to $19.1 billion, a new study found. The study, sponsored by insurance lobbying group America's Health Insurance Plans (AHIP), paints a picture of the costing for testing that will be pivotal for states reopening after months of lockdown due to the pandemic.
VIEW STORY ?

VIEW ALL COVID-19 COVERAGE

This resource has been made possible with support from our industry sponsors

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

FEATURED NEWS STORY
Are Today's Protocols Tomorrow's Routines?
Protocols have changed significantly during the COVID-19 pandemic. Which of those procedures are here to stay and which will disappear as the pandemic subsides? New Retina Radio host John Kitchens, MD, invites Murtaza "Moo" Adam, MD; David R.P. Almeida, MD, PhD, MBA; and Christina Weng, MD, MBA, to discuss which changes implemented in 2020 will be permanent fixtures in retina practice.
VIEW STORY ?

OTHER COVID-19 NEWS
05.20.20
Aldeyra Therapeutics Advances Investigational HSP90 Inhibitor to Clinical Testing for COVID-19
Aldeyra Therapeutics, which has several drug candidates for the treatment of ocular inflammatory diseases, announced the planned advancement of the investigational new HSP90 inhibitor ADX-1612 to clinical testing for COVID-19, and provided an update on ADX-629, a novel investigational RASP inhibitor in development for COVID-19 and other inflammatory diseases.
VIEW STORY ?

05.21.20
Inovio Hints at Positive Early Phase 1 Safety Data for COVID-19 Vaccine INO-4800
Inovio Pharmaceuticals suggested that preliminary safety data from an ongoing phase 1 trial indicates that its experimental COVID-19 DNA vaccine candidate INO-4800 appears to be safe in humans. The phase 1 clinical trial, which began in April, enrolled 40 healthy adult volunteers in the US who will receive two doses of INO-4800, given 4 weeks apart.
VIEW STORY ?

VIEW ALL COVID-19 COVERAGE

This resource has been made possible with support from our industry sponsors

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

Editorially independent content supported with advertising.

MIGS for Severe and Refractory Glaucoma

Blake Williamson, MD, sat down with Neda Shamie, MD, to discuss a retrospective multicenter case series that assessed the short-term safety and efficacy of goniotomy performed with the Kahook Dual Blade (New World Medical) in patients with severe or refractory glaucoma. Can microinvasive glaucoma surgery benefit these patients?

CLICK HERE TO WATCH THE VIDEO

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

.emailview

Enlightening swept-source OCT images with ANTERION

ANTERION^? - the multimodal imaging platform optimized for the anterior segment - provides a high-resolution visualization of the entire anterior segment, from the anterior surface of the cornea to the posterior surface of the lens.

Its revealing swept-source OCT images provide the basis for very precise measurements that are required for cataract and refractive surgery.

Learn more about ANTERION

Transform your clinical workflow with an all-in-one solution

ANTERION is a modular, upgradeable platform. Three applications - the Cornea App, Cataract App, and Metrics App - provide the most important anterior segment examinations and measurements. ANTERION captures corneal topography and tomography, anterior segment metrics, axial length measurement and IOL calculation; all on one platform. Your patients do not need to move to multiple devices, saving you valuable time and space. Fast acquisition and easy operation further improve your clinical workflow.

Cornea App

With the Cornea App, you receive the most important corneal measurements, such as topography, tomography, pachymetry, wavefront analysis and total corneal power, which can be displayed in different layouts customized to your clinical needs.

Find out more...

Cornea App: Cornea evaluation after refractive surgery.

Cataract App

The Cataract App combines key measurements for cataract surgery planning including corneal analysis, anterior chamber depth, lens thickness, and axial length; while an integrated spheric and toric IOL calculator adds convenience to the pre-operative routine.

Find out more...

Cataract App: Toric IOL calculation for an eye with astigmatism.

Metrics App

Use the Metrics App to determine predefined angle parameters or perform free-hand measurements customized to the clinical case.
Beyond commonly used angle parameters, the Metrics App also offers anterior chamber volume, lens thickness and vault.

Find out more...

Keep yourself up-to-date

Would you like to receive updates about educational materials, products, or events? Then register for the Heidelberg Engineering newsletter at www.he-newsletter.com.

Handout Anterior Segment Anatomy

Download Handout Anterior Segment Anatomy here.

View email in your browser

This sponsored message helps support the free educational content produced by Bryn Mawr Communications LLC.

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to Heidelberg Engineering from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

Don''t miss out! There are only 2 days left to register for the BMC Virtual Spring Symposium. Join over 1,500 of your peers and register today for complimentary access.

Register Now to attend

WHAT: A stay-at-home educational meeting designed to connect the ophthalmic community and provide up-to-date information and insights. Tune in for critical updates to the health care community as well as many fun surprises from your colleagues!

WHEN: May 29 and May 30

WHO: Steven Dell, MD; I. Paul Singh, MD; Gary W?rtz, MD; and Neda Shamie, MD, host this exciting 2-day meeting with over 40 esteemed faculty members.

headshots

WHERE: Upon registering, a link will be provided via email to access the virtual meeting.

Register Now to attend

This virtual meeting has been made possible, in part, with support from industry sponsors.

Powering Connectivity in the Ophthalmic Community

@BMC__Vision

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to 2020 BMC Summit from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

NEW EPISODE | June 24, 2020

Video

WATCH THIS WEEK''S EPISODE

IN THIS EPISODE

Johnson & Johnson Vision Receives FDA Clearance for Astigmatism Management Software for Catalys

Viela Bio Receives FDA Approval for Neuromyelitis Optica Spectrum Disorder (NMOSD) Treatment

Vasoptic Medical Receives FDA Clearance for Retinal Imaging Device

VIEW ALL SEGMENTS

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

FEATURED NEWS STORY
First COVID-19 Vaccine Tested In the US Shows Promise in Data From Eight People
Early data from Moderna's COVID-19 vaccine, the first to be tested in the United States, showed that it produced protective antibodies in a small group of healthy volunteers. The data comes from eight people who took part in a 45-subject safety trial that kicked off in March.
VIEW STORY ?

OTHER COVID-19 NEWS
05.18.20
How Retina Specialists Are Responding to Changing Conditions in Their Countries
New Retina Radio host Allen Ho, MD (United States), and guest host Ehab El-Rayes, MD, PhD (Egypt), invite Matteo Forlini, MD (Italy), and Monica L?vestam-Adrian, MD (Sweden), to share their tactics for providing optimal patient care in the wake of a global pandemic.
VIEW STORY ?

05.18.20
AMA Issues Guidance to Physicians On Using COVID-19 Antibody Tests
As new serology tests for COVID-19 rapidly come to the market, the American Medical Association (AMA) is cautioning physicians about using these tests to make health care decisions for individual patients. The AMA issued guidance this week to help physicians understand the potential uses and limitations of serological testing, also called antibody testing.
VIEW STORY ?

VIEW ALL COVID-19 COVERAGE

This resource has been made possible with support from our industry sponsors

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

TOP STORY OF THE WEEK
STAAR Surgical's EVO Viva Presbyopia Correcting Lens Receives CE Mark Approval ?

TRENDING NEWS
07.07.20
Santen Announces FDA Acceptance of Premarket Approval Application for DE-128 (MicroShunt) for Review ?

07.09.20
Vision Expo West 2020 Cancelled; Virtual Offerings Planned ?

07.07.20
Apellis Completes Enrollment in Two Phase 3 Studies of Pegcetacoplan in Patients with Geographic Atrophy (GA) ?

07.10.20
Women in Ophthalmology (WIO) 2020 Summer Symposium Goes Virtual ?

07.08.20
Plex Pharmaceuticals Awarded $1.6 Million in Grant Funding from NIH to Advance Eye Drop Therapy for Cataracts ?

07.09.20
Accelmed Partners Completes Acquisition of TearLab ?

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

TOP STORY OF THE WEEK
Early Data Show Moderna's COVID-19 Vaccine Generates Immune Responses ?

TRENDING NEWS
05.20.20
Are Today's Protocols Tomorrow's Routines? ?

05.20.20
Aldeyra Therapeutics Advances Investigational HSP90 Inhibitor to Clinical Testing for COVID-19 ?

05.18.20
COVID-19: Views From Egypt, Italy, Sweden, and the United States ?

05.19.20
Roche Antibody Test for COVID-19 Goes Live at More Than 20 Initial Lab Sites in the US ?

05.19.20
Avellino Announces A.C.T.S. Program to Help Practices Protect Patients and Staff From COVID-19 ?

05.20.20
New Paper in Clinical and Experimental Optometry Summarizes SARS-CoV-2 Interaction With the Ocular Surface ?

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

NEW ISSUE | JUNE 2020

The latest issue of CRST Europe explores how the current pandemic is causing a paradigm shift in patient care.

READ JUNE ISSUE

THE TOP THREE ARTICLES YOU SHOULD BE READING:

1	Global Perspectives By Amanda Cardwell Carones, MPH; Francesco Carones, MD; John S.M. Chang, MD; Oliver Findl, MD, MBA; Jodhbir S. Mehta, BSc (Hons), MBBS, PhD, FRCOphth, FRCS(Ed), FAMS; and Marcus Ang, MBBS, PhD, FRCS(Ed) How are eye care practitioners from around the world dealing with the return to practice?
2	Premium IOLs in the Post-COVID Era By Arthur B. Cummings, MB ChB, FCS(SA), MMed(Ophth), FRCS(Edin) This surgeon believes that patients will be requesting presbyopia-correcting IOLs at a higher rate than ever before. If that proves to be the case, these lenses could help ophthalmologists to recoup some of the revenue lost during the current pandemic.
3	Shared Care and Patient Flow Post-Lockdown By Sandip Doshi, PhD, BSc, MCOptom Learn how to implement well-defined protocols for comanagement that enhance the patient's experience and reduce the risk of COVID-19 transmission for patients and clinicians alike.

Also in This Issue

A Noninvasive Alternative to Cataract Surgery? ?

Tixel for Crow's Feet, Wrinkles, and Dry Eye Disease ?

Mature Brown Cataract ?

READ JUNE ISSUE ?

FEATURED VIDEO IN
CATARACT

Aerosol During Phacoemulsification: How to Make Cataract Surgery Safe During COVID-19
Asaf Achiron, MD; Derek Tole, MD; Duncan Leadbetter, MD; Johan Keller, MD; Kieren Darcy, MD; Omar El-Haddad, MD; and Sidath Liyanage, MD


	WATCH NOW ON EYETUBE.NET

CATARACT & REFRACTIVE NEWS

06.23.20
United Kingdom to Test Weekly, Swabless COVID-19 Screening for Health Care Workers, Students, and More    READ MORE

06.23.20
Gilead to Begin Human Trials for the Inhaled Version of Coronavirus Drug Remdesivir    READ MORE

06.22.20
Aurinia Completes Patient Enrollment in Phase 2/3 Trial of Voclosporin for the Treatment of Dry Eye    READ MORE

RECENT CRST Europe ISSUES

stay updated on all things Cataract

click here

Advertise | Submit Breaking News | Contact Us

* Free print subscriptions are available to practicing physicians in the US.
All others, applicable subscription charges apply.

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

You received this email because you are subscribed to Cataract & Refractive Surgery Today Europe Newsletter from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us | Legal Disclaimer

NEW EPISODE | July 15, 2020

Video

WATCH THIS WEEK''S EPISODE

IN THIS EPISODE

AAO and Several Other Ophthalmic Groups Move Annual Meetings to Virtual Format

AECOS Summer Symposium Panel Examines COVID-19 Medical Legal Issues

Schwind Receives CE Mark Approval for the Schwind ATOS Femtosecond Laser

VIEW ALL SEGMENTS

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

2021 Caribbean Eye Meeting - Live and In Person In Puerto Rico!

The 2021 Caribbean Eye Meeting will take place live and in person in February, 2021! We understand there is continued uncertainty relating to COVID-19, so we are offering Risk Free Registration*. Please visit our website for the most up to date information including the increased health and safety measures that are being taken by the Hyatt Grand Reserve Puerto Rico and the Hyatt's AimClean Safe Protocols. We continue to be guided by the Centers for Disease Control and Prevention and will alert you if there are any changes to the live meeting as it is currently planned. Please email us with any questions at EventRegistrations@bmctoday.com and we look forward to seeing you in Puerto Rico in 2021!

Register Today Risk Free*

Join us in Puerto Rico for the 2021 Caribbean Eye Meeting February 5- 8, 2021! This interactive, engaging ophthalmic gathering will take place live and in person, and will challenge and inspire you!

CHECK OUT THE TOP TEN VIDEO HIGHLIGHTS FROM THE 2020 MEETING PRESENTATIONS NOW AVAILABLE ONLINE!

The Caribbean Eye Meeting was honored to have Dr. Richard Lindstrom present the Sheets-Martin Lecture during the 2020 Meeting. Watch the video of his outstanding lecture along with videos of the Top Ten presentations from the 2020 Caribbean Eye Meeting by clicking the link below.

Watch Videos Now

Register for the 2021 Meeting RISK FREE and visit our website to book your discounted accommodations at the Hyatt Regency Grand Reserve*!

The Caribbean Eye Meeting is working closely with the Hyatt Regency Grand Reserve Puerto Rico to ensure a safe and worry-free environment for all meeting participants. We are excited to share Hyatt's AimClean Safe Protocols which have been implemented in light of the COVID-19 pandemic. Please visit the meeting website for complete details as well as the most up to date information regarding the event as we continue to monitor the COVID-19 situation at www.caribbeaneyemeeting.com. Take advantage of the Early Bird discounted registration rate until August 31, 2020 and register risk free*!

Register Risk Free

* Visit the meeting website for details about our risk free registration policy.

February 5 - 8, 2021

Hyatt Regency Grand Reserve Puerto Rico

Coco Beach Boulevard 200
R?o Grande, PR 00745

Don''t Miss Out!

Early Registration Discount extended through August 31, 2020!

Use coupon code EARLYBIRD to receive $150 off your registration before August 31, 2020.

Register Today

View email in your browser

This sponsored message helps support the free educational content produced by Bryn Mawr Communications LLC.

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to BMC Group from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

"Is the Angle the New Conjunctiva?"
Making a case for tissue-sparing MIGS.

Dr. I Paul Singh and Dr. Mark J. Gallardo

In this video interview, iTrackT physicians Dr. Inder Paul Singh and Dr. Mark J. Gallardo discuss the importance of preserving the angle with MIGS procedures in order to preserve future treatment options.

"I view the angle as the new conjunctiva, because I want to manipulate it today - but I also want to preserve tissue. We all know in glaucoma that there is not a single procedure that lasts forever. I want to be able to come back and treat the patient with SLT at 360 degrees. I want to be able to implant micro stents in the future, or even try to rejuvenate the system again with another iTrackT procedure." - Mark J. Gallardo, MD

Watch Additional iTrack Videos

"Do No Harm: iTrackT and the Corneal Endothelium"
Delivering on efficacy, without compromising future treatment.

Dr. I Paul Singh, Dr. David Lubeck and Dr. Robert Noecker

In this video interview, doctors Singh, Lubeck and Noecker discuss the interim results of a prospective, multi-center study assessing the stability of endothelial cell density in patients who underwent iTrackT in conjunction with cataract surgery, presented at the Virtual ASCRS Meeting. They also discuss the ability of iTrackT to achieve a reduction in IOP and medication dependence while keeping the door open for future intervention, if needed.

"Endothelial cell loss with iTrack canal based surgery combined with cataract surgery was equivalent to (no greater than) cataract surgery alone."
- Dr. David Lubeck

Watch Video ?

"Going it Alone with MIGS"
Is there a case for performing MIGS outside cataract surgery?

Dr. I Paul Singh, Dr. Mahmoud Khaimi

In this video interview, Dr. Inder Paul Singh and Dr. Mahmoud Khaimi discuss the interim efficacy outcomes of iTrackT as a standalone procedure at 24 months, presented at the Virtual ASCRS Meeting.

"What I''ve taken away from this (iTrackT) data is the confidence to go in as a standalone procedure. Many surgeons are comfortable performing MIGS with a cataract: you''re already going into the eye and patients are going to be happy having improved vision. But to go in as a standalone MIGS procedure, you really want to deliver - and not only IOP reduction, but also medication burden reduction." - Inder P. Singh, MD

Watch Video ?

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to Cataract Collections from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us


What''s New to Eyetube.net: JuLY 2020

Improving Surgical Gonio View

by Jesse Richman, MD

Jesse Richman, MD, describes a simple way of enhancing visualization during angle-based glaucoma procedures.
Watch Now >

Pterygium Surgery With Conjunctival Autograft

by Ashraf Armia, MD

Ashraf Armia, MD, shares the case of a 35-year-old man who presented with progressive pterygium that had caused approximately 3.00 D of astigmatism.
Watch Now >

The Carousel Technique for Soft Cataracts

by Ahmed Assaf, MD, FRCSEd

Ahmed Assaf, MD, FRCSEd, demonstrates the carousel technique for cataract surgery and explains why hydrodelineation is required to facilitate spinning of the nucleus.
Watch Now >

[3D Video] Giant Tear & Retinal Detachment

by Nil?fer Ko?ak, MD

See how Nil?fer Ko?ak, MD, handled the case.
Watch Now >

Fixation of Folding Lenses to Sclera With Gore-Tex and BLIS-X1 Cartridge

by Abel Ram?n, MD; Efra?n Romo, MD; J. Eder Valencia, MD; and Tal?a Romero, MD

Abel Ram?n, MD, and colleagues demonstrate an easy, reproducible technique for suturing an IOL to the sclera that allows the lens to be injected through a conventional phaco incision without needing to enlarge it or create new incisions.
Watch Now >

Other Series:

Ophthalmology off the Grid
Survive & Thrive: Building Your Brand

Clinical Minute
Satisfaction After Refractive Lens Exchange Using an Extended Depth of Focus IOL

Inside the Wills OR
Managing a Torn and Dislocated IOL

BMC Virtual Spring Symposium
Explore the Meeting

Get access to Eyetube''s video library
Register Now ?

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.

Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States

You received this email because you are subscribed to Eyeflash Newsletter from Bryn Mawr Communications LLC.
Manage Preferences | Unsubscribe | Contact Us

FEATURED NEWS STORY
COVID-19: Can Clinical Trials Proceed?
Can clinical trials go forward during the COVID-19 crisis? If so, how? And if not, then how do we proceed? New Retina Radio host John Kitchens, MD, and special co-moderator Namrata Saroj, OD, invite clinical trial veterans Jeffrey Heier, MD; Carl Regillo, MD; and Charles Wykoff, MD, PhD, to discuss the future of one of ophthalmology's most important components.
VIEW STORY ?

OTHER COVID-19 NEWS
04.30.20
Quest, LabCorp Launch Nationwide COVID-19 Antibody Testing in Pharmacies and Online
Weeks after launching their own COVID-19 molecular testing initiatives, lab giants Quest Diagnostics and LabCorp have begun offering antibody tests nationwide for the next phase of the coronavirus pandemic.
VIEW STORY ?

04.29.20
Finding Opportunity in Crisis During COVID-19
COVID-19 has created new opportunities for practice development and will likely reshape how their practices look in the future, according to Neda Shamie, MD, and Daniel S. Durrie, MD, who joined cohosts Gary W?rtz, MD, and Blake Williamson, MD, MPH, on a recent episode of Ophthalmology Off the Grid.
VIEW STORY ?

VIEW ALL COVID-19 COVERAGE

This resource has been made possible with support from our industry sponsors

Advertise | Send a Tip or Event | Contact Us

View email in your browser

Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.

Data Name	Data Type	Options
	Text Box
First name	Text Box
Last name	Text Box
Password	Text Box
Email	Text Box
City	Text Box
State	Text Box
Country	Text Box
	button
	dropdown	Your Occupation
	dropdown	Your Occupation
	dropdown	Your Occupation
	dropdown	Your Occupation
	dropdown	Your Occupation
	dropdown	Your Occupation
	button
	button
I permit Eyetube to send me email updates, Eyetube's enewsletters, Eyewire industry news alerts, and messages from partner organizations.	checklist	Step 4: Confirmation
I have read and agree to the Privacy Policy and Terms & Conditions of this site.	checklist

Start Searching Today!

eye tube Sign Up Information

Email Address

Password

Your Name

Your Address

Post-Registration Data

Validation

Membership Emails

Enlightening swept-source OCT images with ANTERION

Transform your clinical workflow with an all-in-one solution

Cornea App

Cataract App

Metrics App

Keep yourself up-to-date

Handout Anterior Segment Anatomy

Comments about eyetube

Recently added URLs

Top 10 Search URLs

Top 10 Categories